Compound 156
Identifiers
- Canonical SMILES:
CCCCN(CCCC)C(=O)c1cc(C)n(n1)-c1ccccc1C(=O)N1CCc2ccccc2C1
- IUPAC name:
N,N-dibutyl-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methylpyrazole-3-carboxamide
- InChi:
InChI=1S/C29H36N4O2/c1-4-6-17-31(18-7-5-2)29(35)26-20-22(3)33(30-26)27-15-11-10-14-25(27)28(34)32-19-16-23-12-8-9-13-24(23)21-32/h8-15,20H,4-7,16-19,21H2,1-3H3
- InChiKey:
FMDKBLIVRUNPCH-UHFFFAOYSA-N
External links
44570049 |
CHEMBL513318 |
24716121 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.64 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 472.28 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 5.65 | |||
TPSA | 58.44 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5766 | Apixaban | DB06605 | |
0.5147 | Alosetron | DB00969 | |
0.5000 | Meclinertant | DB06455 | |
0.4918 | Granisetron | DB00889 | |
0.4852 | Rimonabant | DB06155 | |
0.4804 | 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole | DB04030 | |
0.4756 | Surinabant | DB13070 | |
0.4750 | 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE | DB08527 | |
0.4604 | Seltorexant | DB14961 | |
0.4564 | JHU-75528 C-11 | DB14902 | |
0.4489 | Eluxadoline | DB09272 | |
0.4486 | PF-06291874 | DB15065 | |
0.4434 | SD146 | DB02729 | |
0.4431 | Raltegravir | DB06817 | |
0.4419 | Acumapimod | DB15448 |